DANA STEWART: Open Payments
NPI 1093012957 · CALHOUN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 31 payments from 14 companies in 2025. Trend: 2023 $1,002 · 2024 $406 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $118 |
| Novo Nordisk Inc | 4 | $91 |
| Exact Sciences Corporation | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Astellas Pharma US Inc | 1 | $22 |
Products named: Cologuard Collection Kit, ELIQUIS, Ozempic, JARDIANCE, Kerendia, XIFAXAN, PREVNAR 20, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
